Back to the main directory
EarningsReview / Equity
- Delivering on inorganic expansion plan by BNP Paribas Exane
- Conference Takeaways: Stepping in as We Step Out by BNP Paribas Exane
- Genmab (Hold, TP: DKK2451.00) - Epcoritamab value increase by DnB Markets
- Pandox (Buy, TP: SEK165.00) - Stay on board by DnB Markets
- ICA (Sell, TP: SEK380.00) - Summary of CMD by DnB Markets
- 2021 all comes down to market share by BNP Paribas Exane
- BW LPG - Heading for 2021 at warp speed by Danske Bank Equity Research
- Investment Daily 10/12/2020 by BNP Paribas Exane
- Rental resilience continues by BNP Paribas Exane
- Swedish Orphan Biovitrum (Buy, TP: SEK259.00) - Summary of CMD by DnB Markets
- Assa Abloy (Buy, TP: SEK235.00) - Slight setback to recovery by DnB Markets
- SKF (Buy, TP: SEK255.00) - Rolling on towards 15% margin by DnB Markets
- Epiroc (Buy, TP: SEK160.00) - Solid as a rock by DnB Markets
- Hexpol (Hold, TP: SEK90.00) - HOLDing on by DnB Markets
- Trelleborg (Hold, TP: SEK190.00) - Improved, but fairly valued by DnB Markets
- Green is good by DnB Markets
- Challenging H1, but encouraging H2 outlook by BNP Paribas Exane
- Don''t Pass Up on Vail with 20% More Passes by BNP Paribas Exane
- Is now the wrong time to mention the ''P'' word? by BNP Paribas Exane
- Systemair - Buy/SEK 270 (276): Two steps forward and one step back by Nordea
- Feedback roadshow Gouvernance Saint-Gobain : une dynamique en marche by Oddo BHF
- A new player in the North American cement market by BNP Paribas Exane
- Jonjee High-Tech (600872 CH) by HSBC
- Trying to get back to 10-12% RoTE target by BNP Paribas Exane
- FQ2 postview: Moving forward by BNP Paribas Exane